Admission NT‐proBNP and outcomes in patients without history of heart failure hospitalized with COVID‐19

Admission NT‐proBNP and outcomes in patients without history of heart failure hospitalized with COVID‐19

Abstract Aims We examined the value of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) in patients admitted for coronavirus disease 2019 (COVID‐19) without prior history of heart failure (HF) or cardiomyopathy. Methods and results Retrospective cohort of consecutive adults (N = 679; median age...

Full description

Bibliographic Details
Main Authors: Jeanwoo Yoo, Prabhjot Grewal, Jessica Hotelling, Aikaterini Papamanoli, Kerry Cao, Simrat Dhaliwal, Robin Jacob, Azad Mojahedi, Michelle E. Bloom, Luis A. Marcos, Hal A. Skopicki, Andreas P. Kalogeropoulos
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:ESC Heart Failure
Subjects:
COVID‐19
NT‐proBNP
Outcomes
Healthcare resources utilization
Mortality
Mechanical ventilation
Online Access:https://doi.org/10.1002/ehf2.13548

Internet

https://doi.org/10.1002/ehf2.13548

Similar Items